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was treated with ondansetron (100 microg/kg i.v.) as the first postoperative anti-emetic. Second-line anti-emetics were also used in case of ondansetron failure.
Study design
This was a prospective, randomised, double-blind controlled trial. The number of centres in which the study was conducted was not reported. Patient allocation to study groups was conducted using a random number generator. The anaesthetist who prepared the study drugs was not involved in patient care. The nursing staff who carried out the patient evaluation was blind to the treatment administered to the children. The patients were followed until discharge from the postanaesthesia care unit (PACU). No loss to follow-up was reported. The outcome assessment was performed at intervals of 0 to 2, 2 to 6, and 6 to 24 hours.
Analysis of effectiveness
The basis of the clinical study appears to have been intention to treat. The primary health outcomes used in the effectiveness analysis were incidence of PONV, incidence of nausea, rescue requirements, rescue anti-emetics (ondansetron, metoclopramide and promethazine), fast tracking time (FTT), PACU stay, the number-needed-to-prevent (NNP) and the number-needed-to-treat (NNT) PONV, a parental satisfaction score, and the number-needed-to-improve satisfaction (NNS). The FTT was calculated as the time from the discontinuation of anaesthesia to the time at which a child had patent airway without support, no PONV or pain, and a modified Aldrete recovery score of 10. Parental satisfaction was scored using an 11-point verbal linear numerical scoring system ranging from 0 ("not at all satisfied") to 10 ("fully satisfied"). The NNS was calculated as the reciprocal of the absolute percentage of unsatisfied parents. The study groups were shown to be comparable at baseline in terms of their demographics and clinical characteristics.
Effectiveness results
Over the 24 postoperative hours, the incidence of PONV was 34.7% in the PO group and 72% in the EO group, (p<0.0001); the incidence of nausea was 40.9% in the PO group and 76.9% in the EO group, (p=0.0009); and the proportion of rescue requirements was 34.7% in the PO group and 72% in the EO group, (p<0.0001).
Ondansetron as first-rescue anti-emetic was used in 34.7% of the PO group and 72% of the EO group, (p<0.0001).
Metoclopramide as second-rescue anti-emetic was used in 9.3% of the PO group and 29.3% of the EO group, (p=0.0019).
Promethazine as third-rescue anti-emetic was used in 2.7% of the PO group and 13.3% of the EO group, (p=0.0351).
The FTT was 21.6 (+/-4.1) minutes in the PO group and 28.2 (+/-5.3) minutes in the EO group, (p<0.0001).
PACU stay was 126.5 (+/-13.9) minutes in the PO group and 141.1 (+/-30.6) minutes in the EO group, (p=0.0002).
The NNP/NNT PONV was 2 in the PO group and 9 in the EO group.
The NNS was 1.6 in the PO group and 4 in the EO group.
The parental satisfaction score was 8.2 (+/-1.8) in the PO group and 6.8 (+/-1.7) in the EO group, (p<0.0001).
Clinical conclusions
The effectiveness analysis showed that the PO strategy was more effective than the EO treatment for the management of PONV in children undergoing strabismus repair. The parents were more satisfied and all outcome measures performed significantly better with PO.
